145 results on '"Pyrimidines"'
Search Results
102. Generation of 500-Member Library of 10-Alkyl-2-R1,3-R2-4,10-Dihydrobenzo[4,5]imidazo[1,2-a]pyrimidin-4-ones.
- Author
-
Sirko, Svetlana M., Gorobets, Nikolay Yu., Musatov, Vladimir I., and Desenko, Sergey M.
- Subjects
- *
PYRIMIDINES , *ALKYLATING agents , *ANTINEOPLASTIC agents , *HETEROCYCLIC compounds , *ORGANIC compounds , *ALKYLATION , *CHEMICAL reactions , *MOLECULAR structure , *CHEMICAL bonds - Abstract
Representative benzimidazopyrimidinones were previously reported to be intercalating antitumor agents. In this work, we used 2-substituted 4,10-dihydrobenzo [4,5]imidazo[1,2-ɑ]pyriminin-4-ones for their diversification by regioselective alkylation. Under the conditions established, the alkylation gave 10-alkyl derivatives which permitted the parallel generation of a 500-member library of the title compounds. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
103. Oxazinethione Derivatives as a Precursor to Pyrazolone and Pyrimidine Derivatives: Synthesis, Biological Activities, Molecular Modeling, ADME, and Molecular Dynamics Studies.
- Author
-
Abdellattif, Magda H., Shahbaaz, Mohd, Arief, M. M. H., and Hussien, Mostafa A.
- Subjects
- *
PYRIMIDINE derivatives , *MOLECULAR dynamics , *PYRAZOLONES , *PYRIMIDINES , *MOLECULAR docking , *ANTINEOPLASTIC agents - Abstract
In this study, we used oxazinethione as a perfect precursor to synthesize new pyrimidine and pyrazole derivatives with potent biological activities. Biological activities were determined for all compounds against A. flavus, E. coli, S. aureus, and F. moniliform. Compounds 3, 4a-b, and 5 exhibited higher activities toward A. flavus, E. coli, S. aureus, and F. moniliform; this was indicated through the MIC (minimum inhibitory concentration). At the same time, anticancer activities were determined through four cell lines, Ovcar-3, Hela, MCF-7, and LCC-MMk. The results obtained indicated that compound 5 was the most potent compound for both cell lines. Molecular docking was studied by the MOE (molecular operating environment). The in silico ADME of compounds 2 and 5 showed good pharmacokinetic properties. The present research strengthens the applicability of these compounds as encouraging anticancer and antibacterial drugs. Moreover, JAGUAR module MD simulations were carried out at about 100 ns. In addition, spectroscopic studies were carried out to establish the reactions of the synthesized structure derivatives. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
104. Design, Synthesis and SAR in 2,4,7-Trisubstituted Pyrido[3,2- d ]Pyrimidine Series as Novel PI3K/mTOR Inhibitors.
- Author
-
Buron, Frédéric, Rodrigues, Nuno, Saurat, Thibault, Hiebel, Marie Aude, Bourg, Stéphane, Bonnet, Pascal, Nehmé, Reine, Morin, Philippe, Percina, Nathalie, Corret, Justine, Vallée, Béatrice, le Guevel, Remy, Jourdan, Marie-Lise, Bénédetti, Hélène, and Routier, Sylvain
- Subjects
- *
PHOSPHATIDYLINOSITOL 3-kinases , *PYRIMIDINES , *KINASES , *MORPHOLINE , *CELL lines , *CANCER cells - Abstract
This work describes the synthesis, enzymatic activities on PI3K and mTOR, in silico docking and cellular activities of various uncommon 2,4,7 trisubstituted pyrido[3,2-d]pyrimidines. The series synthesized offers a chemical diversity in C-7 whereas C-2 (3-hydroxyphenyl) and C-4 groups (morpholine) remain unchanged, in order to provide a better understanding of the molecular determinants of PI3K selectivity or dual activity on PI3K and mTOR. Some C-7 substituents were shown to improve the efficiency on kinases compared to the 2,4-di-substituted pyrimidopyrimidine derivatives used as references. Six novel derivatives possess IC50 values on PI3Kα between 3 and 10 nM. The compounds with the best efficiencies on PI3K and mTOR induced micromolar cytotoxicity on cancer cell lines possessing an overactivated PI3K pathway. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
105. Studies of Interaction Mechanism between Pyrido [3,4- d ] Pyrimidine Inhibitors and Mps1.
- Author
-
Xing, Cheng, Zhou, Xiaoping, Chen, Chengjuan, Sun, Wei, Zheng, Qingchuan, and Liang, Di
- Subjects
- *
MOLECULAR dynamics , *PYRIMIDINES , *MOLECULAR probes , *SMALL molecules , *MOLECULAR docking , *PYRIMIDINE derivatives - Abstract
Monopolar spindle 1 (Mps1), a dual-specific kinase, is related to the proper execution of chromosome biorientation and mitotic checkpoint signaling. The overexpression of Mps1 promotes the occurrence of cancer or the survival of aneuploid cancer cells, in other words, the reduction of Mps1 will severely reduce the viability of human cancer cells. Therefore, Mps1 is a potential target for cancer treatment. Recently, a series of novel pyrido [3,4-d] pyrimidine derivatives targeting Mps1 with high biological activity were synthesized. The crystal structure of Mps1 in complex with pyrido [3,4-d] pyrimidine derivatives was also reported, but there were no specific mechanism studies for this series of small molecule inhibitors. In this study, complexes binding modes were probed by molecular docking and further validated by molecular dynamics simulations and the molecular mechanics/generalized Born surface area (MM/GBSA) method. The results indicated that the van der Waals interactions and the nonpolar solvation energies were responsible to the basis for favorable binding free energies, all inhibitors interacted with residues I531, V539, M602, C604, N606, I607, L654, I663, and P673 of Mps1. By analyzing the hydrogen bonds, we found the residues G605 and K529 in Mps1 formed stable hydrogen bonds with compounds, it was more conducive to activities of Mps1 inhibitors. According to the above analysis, we further designed five new compounds. We found that compounds IV and V were better potential Mps1 inhibitors through docking and ADMET prediction. The obtained new insights not only were helpful in understanding the binding mode of inhibitors in Mps1, but also provided important references for further rational design of Mps1 inhibitors. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
106. Nitrogen-Containing Heterocycles as Significant Molecular Scaffolds for Medicinal and Other Applications.
- Author
-
Frank, Éva and Szőllősi, György
- Subjects
- *
TRIAZINE derivatives , *PYRIMIDINES , *HETEROCYCLIC compounds , *STRUCTURE-activity relationships , *BIOACTIVE compounds - Published
- 2021
- Full Text
- View/download PDF
107. Design, Synthesis and Biological Evaluation of Novel Pyrazolo[1,2,4]triazolopyrimidine Derivatives as Potential Anticancer Agents.
- Author
-
Aliwaini, Saeb, Abu Thaher, Bassam, Al-Masri, Ihab, Shurrab, Nabil, El-Kurdi, Said, Schollmeyer, Dieter, Qeshta, Basem, Ghunaim, Mariam, Csuk, René, Laufer, Stefan, Kaiser, Lars, and Deigner, Hans-Peter
- Subjects
- *
BIOSYNTHESIS , *PYRIMIDINES , *PROTEIN kinase B , *EPIDERMAL growth factor receptors , *BREAST cancer , *ANTINEOPLASTIC agents - Abstract
Three novel pyrazolo-[4,3-e][1,2,4]triazolopyrimidine derivatives (1, 2, and 3) were designed, synthesized, and evaluated for their in vitro biological activity. All three compounds exhibited different levels of cytotoxicity against cervical and breast cancer cell lines. However, compound 1 showed the best antiproliferative activity against all tested tumor cell lines, including HCC1937 and HeLa cells, which express high levels of wild-type epidermal growth factor receptor (EGFR). Western blot analyses demonstrated that compound 1 inhibited the activation of EGFR, protein kinase B (Akt), and extracellular signal-regulated kinase (Erk)1/2 in breast and cervical cancer cells at concentrations of 7 and 11 µM, respectively. The results from docking experiments with EGFR suggested the binding of compound 1 at the ATP binding site of EGFR. Furthermore, the crystal structure of compound 3 (7-(4-bromophenyl)-9-(pyridin-4-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine) was determined by single crystal X-ray analysis. Our work represents a promising starting point for the development of a new series of compounds targeting EGFR. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
108. 4,7-Disubstituted 7 H -Pyrrolo[2,3-d]pyrimidines and Their Analogs as Antiviral Agents against Zika Virus.
- Author
-
Soto-Acosta, Ruben, Jung, Eunkyung, Qiu, Li, Wilson, Daniel J., Geraghty, Robert J., and Chen, Liqiang
- Subjects
- *
ZIKA virus , *ANTIVIRAL agents , *DENGUE viruses , *FLAVIVIRUSES , *DRUG target , *SMALL molecules , *PYRIMIDINES - Abstract
Discovery of compound 1 as a Zika virus (ZIKV) inhibitor has prompted us to investigate its 7H-pyrrolo[2,3-d]pyrimidine scaffold, revealing structural features that elicit antiviral activity. Furthermore, we have demonstrated that 9H-purine or 1H-pyrazolo[3,4-d]pyrimidine can serve as an alternative core structure. Overall, we have identified 4,7-disubstituted 7H-pyrrolo[2,3-d]pyrimidines and their analogs including compounds 1, 8 and 11 as promising antiviral agents against flaviviruses ZIKV and dengue virus (DENV). While the molecular target of these compounds is yet to be elucidated, 4,7-disubstituted 7H-pyrrolo[2,3-d]pyrimidines and their analogs are new chemotypes in the design of small molecules against flaviviruses, an important group of human pathogens. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
109. Novel Bis- and Mono-Pyrrolo[2,3- d ]pyrimidine and Purine Derivatives: Synthesis, Computational Analysis and Antiproliferative Evaluation.
- Author
-
Bistrović Popov, Andrea, Vianelo, Robert, Grbčić, Petra, Sedić, Mirela, Pavelić, Sandra Kraljević, Pavelić, Krešimir, and Raić-Malić, Silvana
- Subjects
- *
PYRIMIDINES , *PYRIMIDINE derivatives , *ALTERNATIVE fuels , *STRUCTURAL optimization , *ULTRASONIC imaging , *PANCREATIC cancer - Abstract
Novel symmetrical bis-pyrrolo[2,3-d]pyrimidines and bis-purines and their monomers were synthesized and evaluated for their antiproliferative activity in human lung adenocarcinoma (A549), cervical carcinoma (HeLa), ductal pancreatic adenocarcinoma (CFPAC-1) and metastatic colorectal adenocarcinoma (SW620) cells. The use of ultrasound irradiation as alternative energy input in Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) shortened the reaction time, increased the reaction efficiency and led to the formation of exclusively symmetric bis-heterocycles. DFT calculations showed that triazole formation is exceedingly exergonic and confirmed that the presence of Cu(I) ions is required to overcome high kinetic requirements and allow the reaction to proceed. The influence of various linkers and 6-substituted purine and regioisomeric 7-deazapurine on their cytostatic activity was revealed. Among all the evaluated compounds, the 4-chloropyrrolo[2,3-d]pyrimidine monomer 5f with 4,4′-bis(oxymethylene)biphenyl had the most pronounced, although not selective, growth-inhibitory effect on pancreatic adenocarcinoma (CFPAC-1) cells (IC50 = 0.79 µM). Annexin V assay results revealed that its strong growth inhibitory activity against CFPAC-1 cells could be associated with induction of apoptosis and primary necrosis. Further structural optimization of bis-chloropyrrolo[2,3-d]pyrimidine with aromatic linker is required to develop novel efficient and non-toxic agent against pancreatic cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
110. Synthesis and Neurotropic Activity of New Heterocyclic Systems: Pyridofuro[3,2- d ]pyrrolo[1,2- a ]pyrimidines, Pyridofuro[3,2- d ]pyrido[1,2- a ]pyrimidines and Pyridofuro[3′,2′:4,5]pyrimido[1,2- a ]azepines.
- Author
-
Sirakanyan, Samvel N., Spinelli, Domenico, Geronikaki, Athina, Kartsev, Victor, Hakobyan, Elmira K., Petrou, Anthi, Paronikyan, Ruzanna G., Nazaryan, Ivetta M., Akopyan, Hasmik H., and Hovakimyan, Anush A.
- Subjects
- *
PYRIMIDINES , *AZEPINES , *GABA receptors , *ORGANIC synthesis , *TRANQUILIZING drugs , *NEUROPEPTIDES , *COGNITIVE ability , *BIOLOGICAL assay - Abstract
Background: Neurotic disturbances, anxiety, neurosis-like disorders, and stress situations are widespread. Benzodiazepine tranquillizers have been found to be among the most effective antianxiety drugs. The pharmacological action of benzodiazepines is due to their interaction with the supra-molecular membrane GABA-a-benzodiazepine receptor complex, linked to the Cl-ionophore. Benzodiazepines enhance GABA-ergic transmission and this has led to a study of the role of GABA in anxiety. The search for anxiolytics and anticonvulsive agents has involved glutamate-ergic, 5HT-ergic substances and neuropeptides. However, each of these well-known anxiolytics, anticonvulsants and cognition enhancers (nootropics) has repeatedly been reported to have many adverse side effects, therefore there is an urgent need to search for new drugs able to restore damaged cognitive functions without causing significant adverse reactions. Objective: Considering the relevance of epilepsy diffusion in the world, we have addressed our attention to the discovery of new drugs in this field Thus our aim is the synthesis and study of new compounds with antiepileptic (anticonvulsant) and not only, activity. Methods: For the synthesis of compounds classical organic methods were used and developed. For the evaluation of biological activity some anticonvulsant and psychotropic methods were used. Results: As a result of multistep reactions 26 new, five-membered heterocyclic systems were obtained. PASS prediction of anticonvulsant activity was performed for the whole set of the designed molecules and probability to be active Pa values were ranging from 0.275 to 0.43. The studied compounds exhibit protection against pentylenetetrazole (PTZ) seizures, anti-thiosemicarbazides effect as well as some psychotropic effect. The biological assays evidenced that some of the studied compounds showed a high anticonvulsant activity by antagonism with pentylenetetrazole. The toxicity of compounds is low and they do not induce muscle relaxation in the studied doses. According to the study of psychotropic activity it was found that the selected compounds have an activating behavior and anxiolytic effects on the models of "open field" and "elevated plus maze" (EPM). The data obtained indicate the anxiolytic (anti-anxiety) activity of the derivatives of pyrimidines, especially pronounced in compounds 6n, 6b, and 7c. The studied compounds increase the latent time of first immobilization on the model of "forced swimming" (FST) and exhibit some antidepressant effect similarly to diazepam. Docking studies revealed that compound 6k bound tightly in the active site of GABAA receptor with a value of the scoring function that estimates free energy of binding (ΔG) at −7.95 kcal/mol, while compound 6n showed the best docking score and seems to be dual inhibitor of SERT transporter as well as 5-HT1A receptor. Conclusions: Тhe selected compounds have an anticonvulsant, activating behavior and anxiolytic effects, at the same time exhibit some antidepressant effect. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
111. Design, Synthesis, and Anticancer Screening for Repurposed Pyrazolo[3,4-d]pyrimidine Derivatives on Four Mammalian Cancer Cell Lines.
- Author
-
Othman, Eman M., Bekhit, Amany A., Anany, Mohamed A., Dandekar, Thomas, Ragab, Hanan M., Wahid, Ahmed, and Brindisi, Margherita
- Subjects
- *
CELL lines , *PYRIMIDINES , *PYRIMIDINE derivatives , *CANCER cells , *CELL proliferation , *CHEMICAL synthesis - Abstract
The present study reports the synthesis of new purine bioisosteres comprising a pyrazolo[3,4-d]pyrimidine scaffold linked to mono-, di-, and trimethoxy benzylidene moieties through hydrazine linkages. First, in silico docking experiments of the synthesized compounds against Bax, Bcl-2, Caspase-3, Ki67, p21, and p53 were performed in a trial to rationalize the observed cytotoxic activity for the tested compounds. The anticancer activity of these compounds was evaluated in vitro against Caco-2, A549, HT1080, and Hela cell lines. Results revealed that two (5 and 7) of the three synthesized compounds (5, 6, and 7) showed high cytotoxic activity against all tested cell lines with IC50 values in the micro molar concentration. Our in vitro results show that there is no significant apoptotic effect for the treatment with the experimental compounds on the viability of cells against A549 cells. Ki67 expression was found to decrease significantly following the treatment of cells with the most promising candidate: drug 7. The overall results indicate that these pyrazolopyrimidine derivatives possess anticancer activity at varying doses. The suggested mechanism of action involves the inhibition of the proliferation of cancer cells. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
112. Functional Pyrazolo[1,5- a ]pyrimidines: Current Approaches in Synthetic Transformations and Uses As an Antitumor Scaffold.
- Author
-
Arias-Gómez, Andres, Godoy, Andrés, Portilla, Jaime, Silva, Vera L. M., and Silva, Artur M. S.
- Subjects
- *
DRUG design , *PHARMACEUTICAL chemistry , *MATERIALS science , *PYRIMIDINES - Abstract
Pyrazolo[1,5-a]pyrimidine (PP) derivatives are an enormous family of N-heterocyclic compounds that possess a high impact in medicinal chemistry and have attracted a great deal of attention in material science recently due to their significant photophysical properties. Consequently, various researchers have developed different synthesis pathways for the preparation and post-functionalization of this functional scaffold. These transformations improve the structural diversity and allow a synergic effect between new synthetic routes and the possible applications of these compounds. This contribution focuses on an overview of the current advances (2015–2021) in the synthesis and functionalization of diverse pyrazolo[1,5-a]pyrimidines. Moreover, the discussion highlights their anticancer potential and enzymatic inhibitory activity, which hopefully could lead to new rational and efficient designs of drugs bearing the pyrazolo[1,5-a]pyrimidine core. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
113. Nitrogenous Compounds from the Antarctic Fungus Pseudogymnoascus sp. HSX2#-11.
- Author
-
Shi, Ting, Zheng, Li, Li, Xiang-Qian, Dai, Jia-Jia, Zhang, Yi-Ting, Yu, Yan-Yan, Hu, Wen-Peng, Shi, Da-Yong, and Tormo, Rubén
- Subjects
- *
METABOLITES , *METHYL formate , *PATHOGENIC fungi , *FUNGI , *DIKETOPIPERAZINES , *PYRIMIDINES - Abstract
The species Pseudogymnoascus is known as a psychrophilic pathogenic fungus which is ubiquitously distributed in Antarctica. While the studies of its secondary metabolites are infrequent. Systematic research of the metabolites of the Antarctic fungus Pseudogymnoascus sp. HSX2#-11 led to the isolation of one new pyridine derivative, 4-(2-methoxycarbonyl-ethyl)-pyridine-2-carboxylic acid methyl ester (1), together with one pyrimidine, thymine (2), and eight diketopiperazines, cyclo-(dehydroAla-l-Val) (3), cyclo-(dehydroAla-l-Ile) (4), cyclo-(dehydroAla-l-Leu) (5), cyclo-(dehydroAla-l-Phe) (6), cyclo-(l-Val-l-Phe) (7), cyclo-(l-Leu-l-Phe) (8), cyclo-(l-Trp-l-Ile) (9) and cyclo-(l-Trp-l-Phe) (10). The structures of these compounds were established by extensive spectroscopic investigation, as well as by detailed comparison with literature data. This is the first report to discover pyridine, pyrimidine and diketopiperazines from the genus of Pseudogymnoascus. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
114. Promising Antidiabetic and Antimicrobial Agents Based on Fused Pyrimidine Derivatives: Molecular Modeling and Biological Evaluation with Histopathological Effect.
- Author
-
Bassyouni, Fatma, Tarek, Mohammad, Salama, Abeer, Ibrahim, Bassant, Salah El Dine, Sawsan, Yassin, Nemat, Hassanein, Amina, Moharam, Maysa, and Abdel-Rehim, Mohamed
- Subjects
- *
PYRIMIDINE derivatives , *ANTI-infective agents , *HISTOPATHOLOGY , *HYPOGLYCEMIC agents , *PYRIMIDINES , *BIOLOGICAL models - Abstract
Diabetes is the most common metabolic disorder in both developing and non-developing countries, and a well-recognized global health problem. The WHO anticipates an increase in cases from 171 million in 2000 to 366 million by 2030. In the present study, we focus on the preparation of pyrimidine derivatives as potential antidiabetic and antimicrobial agents. Thein vivoeffect on total serum glucose concentration, cholesterol and antioxidant activity was assessed in adult male albino Wister rats and compared to the reference drug glimperide. Promising results were observed for compound 5. The histopathological study confirms that compound 5 results in significant activity with liver maintenance. The antimicrobial activities were evaluated against several bacterial strains such as Salmonella typhimurium ATCC 25566, Bacillus cereus, Escherichia coli NRRN 3008, Pseudomonas aeruginosa ATCC 10145, Staphylococcus aureus ATCC 6538and fungi such as Rhizopus oligosporus, Mucor miehei and Asperillus niger. Compounds 4 and 5 showed a good inhibition of the bacterial zone compared to the reference drug cephradine. Finally, we suggest protein targets for these drugs based on computational analysis, and infer their activities from their predicted modes of binding using molecular modeling. The molecular modeling for compounds 4 and 5 resulted in improved docking scores and hydrogen bonding. The docking studies are in good agreement with the in vitro and in vivo studies. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
115. A New Pyrimidine Schiff Base with Selective Activities against Enterococcus faecalis and Gastric Adenocarcinoma.
- Author
-
Stolarczyk, Marcin, Wolska, Aleksandra, Mikołajczyk, Aleksandra, Bryndal, Iwona, Cieplik, Jerzy, Lis, Tadeusz, and Matera-Witkiewicz, Agnieszka
- Subjects
- *
SCHIFF bases , *ENTEROCOCCUS faecalis , *PYRIMIDINES , *CANCER cell growth , *ADENOCARCINOMA , *REACTIVE oxygen species , *LINEZOLID , *FOSFOMYCIN - Abstract
Enterococcus faecalis is known as a significant nosocomial pathogen due to its natural resistance to many antibacterial drugs. Moreover, it was found that E. faecalis infection causes inflammation, production of reactive oxygen species, and DNA damage to human gastric cancer cells, which can induce cancer. In this study, we synthesized and tested the biological activity of a new Schiff base, 5-[(4-ethoxyphenyl)imino]methyl-N-(4-fluorophenyl)-6-methyl-2-phenylpyrimidin-4-amine (3), and compared its properties with an analogous amine (2). In the biological investigation, 3 was found to have antibacterial activity against E. faecalis 29212 and far better anticancer properties, especially against gastric adenocarcinoma (human Caucasian gastric adenocarcinoma), than 2. In addition, both derivatives were non-toxic to normal cells. It is worth mentioning that 3 could potentially inhibit cancer cell growth by inducing cell apoptosis. The results suggest that the presence of the –C=N– bond in the molecule of 3 increases its activity, indicating that 5-iminomethylpyrimidine could be a potent core for further drug discovery research. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
116. Design, Synthesis and Biological Evaluation of New Pyrimidine Derivatives as Anticancer Agents.
- Author
-
Madia, Valentina Noemi, Nicolai, Alice, Messore, Antonella, De Leo, Alessandro, Ialongo, Davide, Tudino, Valeria, Saccoliti, Francesco, De Vita, Daniela, Scipione, Luigi, Artico, Marco, Taurone, Samanta, Taglieri, Ludovica, Di Santo, Roberto, Scarpa, Susanna, and Costi, Roberta
- Subjects
- *
PYRIMIDINES , *BIOSYNTHESIS , *ANTINEOPLASTIC agents , *PYRIMIDINE derivatives , *TRIPLE-negative breast cancer , *SQUAMOUS cell carcinoma - Abstract
Background: Anticancer drug resistance is a challenging phenomenon of growing concern which arises from alteration in drug targets. Despite the fast speed of new chemotherapeutic agent design, the increasing prevalence of this phenomenon requires further research and treatment development. Recently, we reported a new aminopyrimidine compound—namely RDS 344—as a potential innovative anticancer agent. Methods: Herein, we report the design, synthesis, and anti-proliferative activity of new aminopyrimidine derivatives structurally related to RDS 3442 obtained by carrying out substitutions at position 6 of the pyrimidine core and/or on the 2-aniline ring of our hit. The ability to inhibit cell proliferation was evaluated on different types of tumors, glioblastoma, triple-negative breast cancer, oral squamous cell carcinomas and colon cancer plus on human dermal fibroblasts chosen as control of normal cells. Results: The most interesting compound was the N-benzyl counterpart of RDS 3442, namely 2a, that induced a significant decrease in cell viability in all the tested tumor cell lines, with EC50s ranging from 4 and 8 μM, 4–13 times more active of hit. Conclusions: These data suggest a potential role for this class of molecules as promising tool for new approaches in treating cancers of different histotype. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
117. Bicyclic Basic Merbarone Analogues as Antiproliferative Agents.
- Author
-
Spallarossa, Andrea, Lusardi, Matteo, Caneva, Chiara, Profumo, Aldo, Rosano, Camillo, Ponassi, Marco, and Chemat, Farid
- Subjects
- *
PYRIMIDINES , *STRUCTURE-activity relationships , *MOIETIES (Chemistry) - Abstract
Pyrimido-pyrimidine derivatives have been developed as rigid merbarone analogues. In a previous study, these compounds showed potent antiproliferative activity and efficiently inhibited topoisomerase IIα. To further extend the structure–activity relationships on pyrimido-pyrimidines, a novel series of analogues was synthesized by a two-step procedure. Analogues 3–6 bear small alky groups at positions 1 and 3 of the pyrimido-pyrimidine scaffold whereas at position 6a (4-chloro)phenyl substituent was inserted. The basic side chains introduced at position 7 were selected on the basis of the previously developed structure–activity relationships. The antiproliferative activity of the novel compounds proved to be affected by both the nature of the basic side chain and the substituents on the pyrimido-pyrimidine moiety. Derivatives 5d and 5e were identified as the most promising molecules still showing reduced antiproliferative activity in comparison with the previously prepared pyrimido-pyrimidine analogues. In topoisomerase IIα-5d docking complex, the ligand would poorly interact with the enzyme and assume a different orientation in comparison with 1d bioactive conformation. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
118. Recent Trends in Enzyme Inhibition and Activation in Drug Design.
- Author
-
Geronikaki, Athina
- Subjects
- *
SODIUM-glucose cotransporters , *DRUG activation , *ENZYME activation , *DRUG design , *MOLECULAR dynamics , *PROTEIN kinase CK2 , *PYRIMIDINES - Abstract
It is known that enzymes are involved in many pathological conditions, such as inflammation, diabetes, microbial infections, HIV, neoplastic, neglected diseases and others. In the drug design process, the design of potent enzyme inhibitors is a crucial step in the long way of drug development. Finally, the prediction of the interaction of drug-like compounds with multiple targets for HIV-1 treatment using a ligand-based drug design approach was presented. Alvaxanthone was found to be strong TS inhibitor as the anthelminthic drug demonstrating also antiproliferative activity in tumor cells. [Extracted from the article]
- Published
- 2021
- Full Text
- View/download PDF
119. Hybrides of Alkaloid Lappaconitine with Pyrimidine Motif on the Anthranilic Acid Moiety: Design, Synthesis, and Investigation of Antinociceptive Potency.
- Author
-
Cheremnykh, Kirill P., Savelyev, Victor A., Borisov, Sergey A., Ivanov, Igor D., Baev, Dmitry S., Tolstikova, Tatyana G., Vavilin, Valentin A., Shults, Elvira E., Skarzewski, Jacek, and FRSC, Jóhannes Reynisson
- Subjects
- *
AMINOBENZOIC acids , *PYRIMIDINES , *ALKALOIDS , *MOIETIES (Chemistry) , *SONOGASHIRA reaction , *CONOTOXINS , *ARYL iodides , *PYRETHROIDS - Abstract
Convenient and efficient routes to construct hybrid molecules containing diterpene alkaloid lappaconitine and pyrimidine fragments are reported. One route takes place via first converting of lappaconitine to 1-ethynyl-lappaconitine, followed by the Sonogashira cross-coupling-cyclocondensation sequences. The other involves the palladium-catalyzed carbonylative Sonogashira reaction of 5′-iodolappaconitine with aryl acetylene and Mo (CO)6 as the CO source in acetonitrile and subsequent cyclocondensation reaction of the generated alkynone with amidines. The reaction proceeded cleanly in the presence of the PdCl2-(1-Ad)2PBn∙HBr catalytic system. The protocol provides mild reaction conditions, high yields, and high atom and step-economy. Pharmacological screening of lappaconitine-pyrimidine hybrids for antinociceptive activity in vivo revealed that these compounds possessed high activity in experimental pain models, which was dependent on the nature of the substituent in the 2 and 6 positions of the pyrimidine nucleus. Docking studies were undertaken to gain insight into the possible binding mode of these compounds with the voltage-gated sodium channel 1.7. The moderate toxicity of the leading compound 12 (50% lethal dose (LD50) value was more than 600 mg/kg in vivo) and cytotoxicity to cancer cell lines in vitro encouraged the further design of therapeutically relevant analogues based on this novel type of lappaconitine–pyrimidine hybrids. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
120. Synthesis of Novel 2-(Pyridin-2-yl) Pyrimidine Derivatives and Study of Their Anti-Fibrosis Activity.
- Author
-
Gu, Yi-Fei, Zhang, Yue, Yue, Feng-li, Li, Shao-tong, Zhang, Zhuo-qi, Li, Jing, and Bai, Xu
- Subjects
- *
PYRIMIDINE derivatives , *PYRIMIDINES , *PHARMACEUTICAL chemistry , *HETEROCYCLIC compounds , *LIVER cells , *MOIETIES (Chemistry) - Abstract
A pyrimidine moiety exhibiting a wide range of pharmacological activities has been employed in the design of privileged structures in medicinal chemistry. To prepare libraries of novel heterocyclic compounds with potential biological activities, a series of novel 2-(pyridin-2-yl) pyrimidine derivatives were designed, synthesized and their biological activities were evaluated against immortalized rat hepatic stellate cells (HSC-T6). Fourteen compounds were found to present better anti-fibrotic activities than Pirfenidone and Bipy55′DC. Among them, compounds ethyl 6-(5-(p-tolylcarbamoyl)pyrimidin-2-yl)nicotinate (12m) and ethyl 6-(5-((3,4-difluorophenyl)carbamoyl)pyrimidin-2-yl)nicotinate (12q) show the best activities with IC50 values of 45.69 μM and 45.81 μM, respectively. Furthermore, the study of anti-fibrosis activity was evaluated by Picro-Sirius red staining, hydroxyproline assay and ELISA detection of Collagen type I alpha 1 (COL1A1) protein expression. Our study showed that compounds 12m and 12q effectively inhibited the expression of collagen, and the content of hydroxyproline in cell culture medium in vitro, indicating that compounds 12m and 12q might be developed the novel anti-fibrotic drugs. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
121. Synthesis, In Silico Prediction and In Vitro Evaluation of Antitumor Activities of Novel Pyrido[2,3- d ]pyrimidine, Xanthine and Lumazine Derivatives.
- Author
-
El-Kalyoubi, Samar, Agili, Fatimah, Keglevich, György, and Moreau, Pascale
- Subjects
- *
AROMATIC aldehydes , *ETHYL acetoacetate , *XANTHINE , *FORECASTING , *PYRIMIDINES , *MASS spectrometry , *LUNG cancer - Abstract
Ethyl 5-arylpyridopyrimidine-6-carboxylates 3a–d were prepared as a one pot three component reaction via the condensation of different aromatic aldehydes and ethyl acetoacetate with 6-amino-1-benzyluracil 1a under reflux condition in ethanol. Additionally, condensation of ethyl 2-(2-hydroxybenzylidene) acetoacetate with 6-amino-1-benzyluracil in DMF afforded 6-acetylpyridopyrimidine-7-one 3e; a facile, operationally, simple and efficient one-pot synthesis of 8-arylxanthines 6a–f is reported by refluxing 5,6-diaminouracil 4 with aromatic aldehydes in DMF. Moreover, 6-aryllumazines 7a–d was obtained via the reaction of 5,6-diaminouracil with the appropriate aromatic aldehydes in triethyl orthoformate under reflux condition. The synthesized compounds were characterized by spectral (1H-NMR, 13C-NMR, IR and mass spectra) and elemental analyses. The newly synthesized compounds were screened for their anticancer activity against lung cancer A549 cell line. Furthermore, a molecular-docking study was employed to determine the possible mode of action of the synthesized compounds against a group of proteins highly implicated in cancer progression, especially lung cancer. Docking results showed that compounds 3b, 6c, 6d, 6e, 7c and 7d were the best potential docked compounds against most of the tested proteins, especially CDK2, Jak2, and DHFR proteins. These results are in agreement with cytotoxicity results, which shed a light on the promising activity of these novel six heterocyclic derivatives for further investigation as potential chemotherapeutics. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
122. Design of Anticancer 2,4-Diaminopyrimidines as Novel Anoctamin 1 (ANO1) Ion Channel Blockers.
- Author
-
Kim, Taewoo, Cho, Sinyoung, Oh, Haejun, Hur, Joonseong, Kim, Haedong, Choi, Young-Ho, Jeon, Seongho, Yang, Young Duk, Kim, Seok-Ho, and Massa, Antonio
- Subjects
- *
ION channels , *GASTROINTESTINAL stromal tumors , *MOIETIES (Chemistry) , *PARATHYROID glands , *PYRIMIDINES - Abstract
Pyrimidine is a privileged scaffold in many synthetic compounds exhibiting diverse pharmacological activities, and is used for therapeutic applications in a broad spectrum of human diseases. In this study, we prepared a small set of pyrimidine libraries based on the structure of two hit compounds that were identified through the screening of an in-house library in order to identify an inhibitor of anoctamin 1 (ANO1). ANO1 is amplified in various types of human malignant tumors, such as head and neck, parathyroid, and gastrointestinal stromal tumors, as well as in breast, lung, and prostate cancers. After initial screening and further structure optimization, we identified Aa3 as a dose-dependent ANO1 blocker. This compound exhibited more potent anti-cancer activity in the NCI-H460 cell line, expressing high levels of ANO1 compared with that in A549 cells that express low levels of ANO1. Our results open a new direction for the development of small-molecule ANO1 blockers composed of a pyrimidine scaffold and a nitrogen-containing heterocyclic moiety, with drug-like properties. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
123. Design, Synthesis and Bioactivity Evaluation of 4,6-Disubstituted Pyrido[3,2-d]pyrimidine Derivatives as Mnk and HDAC Inhibitors.
- Author
-
Xing, Kun, Zhang, Jian, Han, Yu, Tong, Tong, Liu, Dan, and Zhao, Linxiang
- Subjects
- *
PYRIMIDINES , *PYRIMIDINE derivatives , *HISTONE deacetylase inhibitors , *INHIBITION of cellular proliferation , *HYDROXAMIC acids , *TUMOR growth - Abstract
Both HDACs and Mnks play important role in translating multiple oncogenic signaling pathways during oncogenesis. As HDAC and Mnk are highly expressed in a variety of tumors; thus simultaneous inhibit HDAC and Mnk can increase the inhibition of tumor cell proliferation and provide a new way of inhibiting tumor growth. Based on the previous work and the merge pharmacophore method; we designed and synthesized a series of 4,6-disubstituted pyrido[3,2-d]pyrimidine derivatives as HDAC and Mnk dual inhibitors. Among them; compound A12 displayed good HDAC and Mnk inhibitory activity. In vitro antiproliferative assay; compound A12 exhibited the best antiproliferative activity against human prostate cancer PC-3 cells. Docking study revealed that the pyrido[3,2-d]pyrimidine framework and hydroxamic acid motif of compound A12 were essential for maintaining the activity of HDAC and Mnk. These result indicated that A12 was a potent Mnk /HDAC inhibitor and will be further researched. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
124. Synthesis and Biological Activity of New 7-Amino-oxazolo[5,4-d]Pyrimidine Derivatives.
- Author
-
Sochacka-Ćwikła, Aleksandra, Regiec, Andrzej, Zimecki, Michał, Artym, Jolanta, Zaczyńska, Ewa, Kocięba, Maja, Kochanowska, Iwona, Bryndal, Iwona, Pyra, Anna, and Mączyński, Marcin
- Subjects
- *
BIOSYNTHESIS , *PYRIMIDINE derivatives , *PYRIMIDINES , *TUMOR necrosis factors , *NUCLEAR magnetic resonance spectroscopy , *CELL lines - Abstract
The synthesis of a series of novel 7-aminooxazolo[5,4-d]pyrimidines 5, transformations during their synthesis and their physicochemical characteristics have been described. Complete detailed spectral analysis of the intermediates 2–4, the N′-cyanooxazolylacetamidine by-products 7 and final compounds 5 has been carried out using MS, IR, 1D and 2D NMR spectroscopy. Theoretical research was carried out to explain the privileged formation of 7-aminooxazolo[5,4-d]pyrimidines in relation to the possibility of their isomer formation and the related thermodynamic aspects. Additionally, the single-crystal X-ray diffraction analysis for 5h was reported. Ten 7-aminooxazolo[5,4-d]pyrimidines 5 (SCM1–10) were biologically tested in vitro to preliminarily evaluate their immunological, antiviral and anticancer activity. Compounds SCM5 and SCM9 showed the best immunoregulatory profile. The compounds displayed low-toxicity and strongly inhibited phytohemagglutinin A-induced proliferation of human peripheral blood lymphocytes and lipopolysaccharide-induced proliferation of mouse splenocytes. Compound SCM9 caused also a moderate suppression of tumor necrosis factor α (TNF-α) production in a human whole blood culture. Of note, the compounds also inhibited the growth of selected tumor cell lines and inhibited replication of human herpes virus type-1 (HHV-1) virus in A-549 cell line. Molecular investigations showed that the compounds exerted differential changes in expression of signaling proteins in Jurkat and WEHI-231 cell lines. The activity of SCM5 is likely associated with elicitation of cell signaling pathways leading to cell apoptosis. The compounds may be of interest in terms of therapeutic utility as inhibitors of autoimmune disorders, virus replication and antitumor agents. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
125. Chemistry of Fluorinated Pyrimidines in the Era of Personalized Medicine.
- Author
-
Gmeiner, William H.
- Subjects
- *
TRANSFER RNA , *INDIVIDUALIZED medicine , *DNA topoisomerase I , *THYMIDYLATE synthase , *CATALYTIC RNA , *PYRIMIDINES - Abstract
We review developments in fluorine chemistry contributing to the more precise use of fluorinated pyrimidines (FPs) to treat cancer. 5-Fluorouracil (5-FU) is the most widely used FP and is used to treat > 2 million cancer patients each year. We review methods for 5-FU synthesis, including the incorporation of radioactive and stable isotopes to study 5-FU metabolism and biodistribution. We also review methods for preparing RNA and DNA substituted with FPs for biophysical and mechanistic studies. New insights into how FPs perturb nucleic acid structure and dynamics has resulted from both computational and experimental studies, and we summarize recent results. Beyond the well-established role for inhibiting thymidylate synthase (TS) by the 5-FU metabolite 5-fluoro-2′-deoxyuridine-5′-O-monophosphate (FdUMP), recent studies have implicated new roles for RNA modifying enzymes that are inhibited by 5-FU substitution including tRNA methyltransferase 2 homolog A (TRMT2A) and pseudouridylate synthase in 5-FU cytotoxicity. Furthermore, enzymes not previously implicated in FP activity, including DNA topoisomerase 1 (Top1), were established as mediating FP anti-tumor activity. We review recent literature summarizing the mechanisms by which 5-FU inhibits RNA- and DNA-modifying enzymes and describe the use of polymeric FPs that may enable the more precise use of FPs for cancer treatment in the era of personalized medicine. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
126. Polyhalonitrobutadienes as Versatile Building Blocks for the Biotargeted Synthesis of Substituted N-Heterocyclic Compounds †.
- Author
-
Zapol'skii, Viktor A., Bilitewski, Ursula, Kupiec, Sören R., Ramming, Isabell, and Kaufmann, Dieter E.
- Subjects
- *
HETEROCYCLIC compounds , *THIOPHENES , *THIOPHENE derivatives , *IMIDAZOLIDINES , *STAPHYLOCOCCUS aureus , *PYRIMIDINES , *INDOLE - Abstract
Substituted nitrogen heterocycles are structural key units in many important pharmaceuticals. A new synthetic approach towards heterocyclic compounds displaying antibacterial activity against Staphylococcus aureus or cytotoxic activity has been developed. The selective synthesis of a series of 64 new N-heterocycles from the three nitrobutadienes 2-nitroperchloro-1,3-butadiene, 4-bromotetrachloro-2-nitro-1,3-butadiene and (Z)-1,1,4-trichloro-2,4-dinitrobuta-1,3-diene proved feasible. Their reactions with N-, O- and S-nucleophiles provide rapid access to push-pull substituted benzoxazolines, benzimidazolines, imidazolidines, thiazolidinones, pyrazoles, pyrimidines, pyridopyrimidines, benzoquinolines, isothiazoles, dihydroisoxazoles, and thiophenes with unique substitution patterns. Antibacterial activities of 64 synthesized compounds were examined. Additionally, seven compounds (thiazolidinone, nitropyrimidine, indole, pyridopyrimidine, and thiophene derivatives) exhibited a significant cytotoxicity with IC50-values from 1.05 to 20.1 µM. In conclusion, it was demonstrated that polyhalonitrobutadienes have an interesting potential as structural backbones for a variety of highly functionalized, pharmaceutically active heterocycles. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
127. Efficient Access to 3,5-Disubstituted 7-(Trifluoromethyl)pyrazolo[1,5-a]pyrimidines Involving SNAr and Suzuki Cross-Coupling Reactions.
- Author
-
Jismy, Badr, Tikad, Abdellatif, Akssira, Mohamed, Guillaumet, Gérald, Abarbri, Mohamed, Silva, Artur M. S., and Dohi, Toshifumi
- Subjects
- *
SUZUKI reaction , *PYRIMIDINES , *BORONIC acids , *LACTAMS , *KINASE inhibitors , *ARYLATION , *AMINES - Abstract
An efficient and original synthesis of various 3,5-disubstituted 7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidines is reported. A library of compounds diversely substituted in C-3 and C-5 positions was easily prepared from a common starting material, 3-bromo-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-5-one. In C-5 position, a SNAr type reaction was achieved by first activating the C–O bond of the lactam function with PyBroP (Bromotripyrrolidinophosphonium hexafluorophosphate), followed by the addition of amine or thiol giving monosubstituted derivatives, whereas in C-3 position, arylation was performed via Suzuki–Miyaura cross-coupling using the commercially available aromatic and heteroaromatic boronic acids. Moreover, trifluoromethylated analogues of potent Pim1 kinase inhibitors were designed following our concise synthetic methodology. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
128. Biological Evaluation and Molecular Docking with In Silico Physicochemical, Pharmacokinetic and Toxicity Prediction of Pyrazolo[1,5-a]pyrimidines.
- Author
-
Naglah, Ahmed M., Askar, Ahmed A., Hassan, Ashraf S., Khatab, Tamer K., Al-Omar, Mohamed A., Bhat, Mashooq A., Carbone, Anna, and Bertozzi, Fabio
- Subjects
- *
MOLECULAR docking , *CARCINOGENICITY testing , *FORECASTING , *ALKALINE phosphatase , *PYRIMIDINES , *PEPTIDASE , *DEMETHYLASE - Abstract
Pyrazolo[1,5-a]pyrimidines 5a–c, 9a–c and 13a–i were synthesized for evaluation of their in vitro antimicrobial properties against some microorganisms and their immunomodulatory activity. The biological activities of pyrazolo[1,5-a]pyrimidines showed that the pyrazolo[1,5-a]pyrimidines (5c, 9a, 9c, 13a, 13c, 13d, 13e and 13h) displayed promising antimicrobial and immunomodulatory activities. Studying the in silico predicted physicochemical, pharmacokinetic, ADMET and drug-likeness properties for the pyrazolo[1,5-a]pyrimidines 5a–c, 9a–c and 13a–i confirmed that most of the compounds (i) were within the range set by Lipinski's rule of five, (ii) show higher gastrointestinal absorption and inhibition of some CYP isoforms, and (iii) have a carcinogenicity test that was predicted as negative and hERG test that presented medium risk. Moreover, the molecular docking study demonstrated that the compounds 5c, 9a, 9c, 13a, 13c, 13d, 13e and 13h are potent inhibitors of 14-alpha demethylase, transpeptidase and alkaline phosphatase enzymes. This study could be valuable in the discovery of a new series of drugs. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
129. Synthesis of New Series of 2-C-(β-D-glucopyranosyl)-Pyrimidines and Their Evaluation as Inhibitors of Some Glycoenzymes.
- Author
-
Szennyes, Eszter, Gyémánt, Gyöngyi, Somsák, László, Bokor, Éva, and Nicolotti, Orazio
- Subjects
- *
GLYCOGEN phosphorylase , *ACID derivatives , *PYRIMIDINE derivatives , *PYRIMIDINES , *HETEROCYCLIC compounds , *GLYCANS - Abstract
Despite the substantial interest in C-glycosyl heterocycles as mimetics of biologically active native glycans, the appearance of C-glycopyranosyl derivatives of six-membered heterocycles, both in synthetic and biological contexts, is rather scarce. As part of our ongoing research program aimed at preparing hitherto barely known 2-C-glycopyranosyl pyrimidines, the goal of the present study was to synthesize new 5-mono- and multiply substituted derivatives of this compound class. Thus, 2-C-(β-D-glucopyranosyl)-5,6-disubstituted-pyrimidin-4(3H)-ones and 4-amino-2-C-(β-D-glucopyranosyl)-5,6-disubstituted-pyrimidines were prepared by base-mediated cyclocondensations of O-perbenzylated and O-unprotected C-(β-D-glucopyranosyl) formamidine hydrochlorides with methylenemalonic acid derivatives. The 2-C-(β-D-glucopyranosyl)-5-substituted-pyrimidines were obtained from the same amidine precursors upon treatment with vinamidinium salts. The deprotected derivatives of these pyrimidines were tested as inhibitors of some glycoenzymes. None of them showed inhibitory activity towards glycogen phosphorylase and α- and β-glucosidase enzymes, but some members of the sets exhibited moderate inhibition against bovine liver β-galactosidase. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
130. Revisiting the Structure and Chemistry of 3(5)-Substituted Pyrazoles.
- Author
-
Secrieru, Alina, O'Neill, Paul Michael, Cristiano, Maria Lurdes Santos, Branco, Paula Sério, and Siopa, Filipa
- Subjects
- *
PYRAZOLES , *PYRIMIDINES , *ORGANIC synthesis , *CARBENE synthesis , *CHEMISTRY - Abstract
Pyrazoles are known as versatile scaffolds in organic synthesis and medicinal chemistry, often used as starting materials for the preparation of more complex heterocyclic systems with relevance in the pharmaceutical field. Pyrazoles are also interesting compounds from a structural viewpoint, mainly because they exhibit tautomerism. This phenomenon may influence their reactivity, with possible impact on the synthetic strategies where pyrazoles take part, as well as on the biological activities of targets bearing a pyrazole moiety, since a change in structure translates into changes in properties. Investigations of the structure of pyrazoles that unravel the tautomeric and conformational preferences are therefore of upmost relevance. 3(5)-Aminopyrazoles are largely explored as precursors in the synthesis of condensed heterocyclic systems, namely pyrazolo[1,5-a]pyrimidines. However, the information available in the literature concerning the structure and chemistry of 3(5)-aminopyrazoles is scarce and disperse. We provide a revision of data on the present subject, based on investigations using theoretical and experimental methods, together with the applications of the compounds in synthesis. It is expected that the combined information will contribute to a deeper understanding of structure/reactivity relationships in this class of heterocycles, with a positive impact in the design of synthetic methods, where they take part. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
131. Inhibitors of Brassinosteroid Biosynthesis and Signal Transduction.
- Author
-
Rozhon, Wilfried, Akter, Sonia, Fernandez, Atiara, Poppenberger, Brigitte, and Iriti, Marcello
- Subjects
- *
CELLULAR signal transduction , *BIOSYNTHESIS , *PLANT hormones , *CHEMICAL inhibitors , *MOLECULAR genetics , *PLANT development - Abstract
Chemical inhibitors are invaluable tools for investigating protein function in reverse genetic approaches. Their application bears many advantages over mutant generation and characterization. Inhibitors can overcome functional redundancy, their application is not limited to species for which tools of molecular genetics are available and they can be applied to specific tissues or developmental stages, making them highly convenient for addressing biological questions. The use of inhibitors has helped to elucidate hormone biosynthesis and signaling pathways and here we review compounds that were developed for the plant hormones brassinosteroids (BRs). BRs are steroids that have strong growth-promoting capacities, are crucial for all stages of plant development and participate in adaptive growth processes and stress response reactions. In the last two decades, impressive progress has been made in BR inhibitor development and application, which has been instrumental for studying BR modes of activity and identifying and characterizing key players. Both, inhibitors that target biosynthesis, such as brassinazole, and inhibitors that target signaling, such as bikinin, exist and in a comprehensive overview we summarize knowledge and methodology that enabled their design and key findings of their use. In addition, the potential of BR inhibitors for commercial application in plant production is discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
132. Pyrido[2,3-d]pyrimidin-7(8H)-ones: Synthesis and Biomedical Applications.
- Author
-
Jubete, Guillem, Puig de la Bellacasa, Raimon, Estrada-Tejedor, Roger, Teixidó, Jordi, and Borrell, José I.
- Subjects
- *
DNA , *RNA , *PATENTS , *PYRIMIDINES , *NITROGEN - Abstract
Pyrido[2,3-d]pyrimidines (1) are a type of privileged heterocyclic scaffolds capable of providing ligands for several receptors in the body. Among such structures, our group and others have been particularly interested in pyrido[2,3-d]pyrimidine-7(8H)-ones (2) due to the similitude with nitrogen bases present in DNA and RNA. Currently there are more than 20,000 structures 2 described which correspond to around 2900 references (half of them being patents). Furthermore, the number of references containing compounds of general structure 2 have increased almost exponentially in the last 10 years. The present review covers the synthetic methods used for the synthesis of pyrido[2,3-d]pyrimidine-7(8H)-ones (2), both starting from a preformed pyrimidine ring or a pyridine ring, and the biomedical applications of such compounds. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
133. Synthesis and Antimicrobial Evaluation of Novel Pyrazolopyrimidines Incorporated with Mono- and Diphenylsulfonyl Groups.
- Author
-
Alsaedi, Amani M. R., Farghaly, Thoraya. A., and Shaaban, Mohamed R.
- Subjects
- *
SULFONE derivatives , *PYRIMIDINES , *STRUCTURE-activity relationships - Abstract
A novel series of pyrazolo[1,5-a]pyrimidine ring systems containing phenylsulfonyl moiety have been synthesized via the reaction of 2-(phenylsulfonyl)-1-(4-(phenylsulfonyl) phenyl)ethan-1-one, 2-benzenesulfonyl-1-(4-benzenesulfonyl-phenyl)-3-dimethylamino-propenone and 3-(dimethylamino)-1-(4-(phenylsulfonyl)phenyl)prop-2-en-1-one each with various substituted aminoazopyrazole derivatives in one pot reaction strategy. The proposed structure as well as the mechanism of their reactions were discussed and proved with all possible spectral data. The results of antimicrobial activities of the new sulfone derivatives revealed that several derivatives showed activity exceeding the activity of reference drug. Contrary to expectations, we found that derivatives containing one sulfone group are more effective against all bacteria and fungi used than those contain two sulfone groups. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
134. Synthesis, Antitumor Activity, and Docking Analysis of New Pyrido[3′,2′:4,5]furo(thieno)[3,2-d]pyrimidin-8-amines.
- Author
-
Sirakanyan, Samvel N., Spinelli, Domenico, Geronikaki, Athina, Hakobyan, Elmira K., Sahakyan, Harutyun, Arabyan, Erik, Zakaryan, Hovakim, Nersesyan, Lusine E., Aharonyan, Anahit S., Danielyan, Irina S., Muradyan, Rafayel E., Hovakimyan, Anush A., Boga, Carla, and Micheletti, Gabriele
- Subjects
- *
IMIDAZOPYRIDINES , *PYRIMIDINES , *HETEROCYCLIC compounds , *STRUCTURE-activity relationships , *AMINES - Abstract
Continuing our research in the field of new heterocyclic compounds, herein we report on the synthesis and antitumor activity of new amino derivatives of pyrido[3′,2′:4,5](furo)thieno[3,2-d]pyrimidines as well as of two new heterocyclic systems: furo[2–e]imidazo[1,2-c]pyrimidine and furo[2,3-e]pyrimido[1,2-c]pyrimidine. Thus, by refluxing the 8-chloro derivatives of pyrido[3′,2′:4,5]thieno(furo)[3,2-d]pyrimidines with various amines, the relevant pyrido[3′,2′:4,5]thieno(furo)[3,2-d]pyrimidin-8-amines were obtained. Further, the cyclization of some amines under the action of phosphorus oxychloride led to the formation of new heterorings: imidazo[1,2-c]pyrimidine and pyrimido[1,2-c]pyrimidine. The possible antitumor activity of the newly synthesized compounds was evaluated in vitro. The biological tests evidenced that some of them showed pronounced antitumor activity. A study of the structure–activity relationships revealed that the compound activity depended mostly on the nature of the amine fragments. A docking analysis was also performed for the most active compounds. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
135. Synthesis and Evaluation of Pyrimidine Steroids as Antiproliferative Agents.
- Author
-
Cortés-Percino, Alejandra, Vega-Báez, José Luis, Romero-López, Anabel, Puerta, Adrián, Merino-Montiel, Penélope, Meza-Reyes, Socorro, Padrón, José M., and Montiel-Smith, Sara
- Subjects
- *
P-glycoprotein , *PYRIMIDINE synthesis , *RING formation (Chemistry) , *STEROIDS , *PYRIMIDINES , *DRUG resistance , *KETONES - Abstract
A small and focused library of steroidal non-fused and fused pyrimidines was prepared from pregnenolone acetate and diosgenin, respectively. The key step was the cycloaddition reaction of nitrogen-containing 1,3-binucleophiles with the steroidal α,β-unsaturated ketone. Urea, thiourea and guanidine reacted in a similar manner and afforded the steroidal pyrimidines in good yields. The antiproliferative tests against human tumor cell lines gave GI50 values in the micromolar range and had no effect on healthy fibroblasts. Additional experiments indicated that the compounds did not act as P-glycoprotein substrates, thus avoiding the rise of drug resistance. The fused steroidal pyrimidinethione was selected as drug lead for further testing due to its strong antiproliferative activities within the low micromolar range. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
136. Synthesis of Cyclobutane Analogue 4: Preparation of Purine and Pyrimidine Carbocyclic Nucleoside Derivatives.
- Author
-
Hasaneen, Noha, Ebead, Abdelaziz, Hassan, Muhammad Murtaza, Afifi, Hanan, Hunter, Howard, Lee-Ruff, Edward, El-Gohary, Nadia S., Maarouf, Azza R., El-Emam, Ali A., Seley-Radtke, Katherine L., and Dayie, Theodore K.
- Subjects
- *
NUCLEOSIDE derivatives , *CYCLOBUTANE , *PYRIMIDINE nucleosides , *PYRIMIDINES , *SODIUM borohydride , *STEREOCHEMISTRY , *URACIL - Abstract
The coupling of 2-bromo-3-benzoyloxycyclobutanone with purine under basic conditions produces two regioisomers consisting of the N-7 and N-9 alkylated products in equal amounts in their racemic forms. The distribution of the isomers is consistent with the charge delocalization between the N-7 and N-9 positions of the purinyl anion. The structural assignments and relative stereochemistry of each regioisomer were based on 1 and 2D NMR techniques. The relative stereochemistry of the C-2 and C-3 substituents in each regioisomer was the trans orientation consistent with steric factors in the coupling step. The N-9 regioisomer was reduced with sodium borohydride to give the all trans cyclobutanol as the major product in a stereoselective manner. The alcohol was debenzoylated with sodium methoxide in a transesterification step to give the nucleoside analogue. The regioisomeric pyrimidine nucleosides were prepared by Vorbrüggen coupling of the 3-hydroxymethylcyclobutanone triflate with either thymine or uracil followed by stereoselective hydride addition. Regiospecificity of the coupling at the N-1 position was observed and stereoselective reduction to the trans-disubstituted cyclobutanol structure assignments was based on NMR data. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
137. Synthesis and Biological Evaluation of Disubstituted Pyrimidines as Selective 5-HT2C Agonists.
- Author
-
Kim, Juhyeon, Kim, Yoon Jung, Londhe, Ashwini M., Pae, Ae Nim, Choo, Hyunah, Kim, Hak Joong, and Min, Sun-Joon
- Subjects
- *
BIOSYNTHESIS , *PYRIMIDINES , *BINDING site assay , *PLASMA stability , *PYRIMIDINE derivatives , *PYRIMIDINE synthesis - Abstract
Here, we describe the synthesis of disubstituted pyrimidine derivatives and their biological evaluation as selective 5-HT2C agonists. To improve selectivity for 5-HT2C over other subtypes, we synthesized two series of disubstituted pyrimidines with fluorophenylalkoxy groups at either the 5-position or 4-position and varying cyclic amines at the 2-position. The in vitro cell-based assay and binding assay identified compounds 10a and 10f as potent 5-HT2C agonists. Further studies on selectivity to 5-HT subtypes and drug-like properties indicated that 2,4-disubstituted pyrimidine 10a showed a highly agonistic effect on the 5-HT2C receptor, with excellent selectivity, as well as exceptional drug-like properties, including high plasma and microsomal stability, along with low CYP inhibition. Thus, pyrimidine 10a could be considered a viable lead compound as a 5-HT2C selective agonist. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
138. Synthesis, Crystal Structure, and Biological Evaluation of Fused Thiazolo[3,2-a]Pyrimidines as New Acetylcholinesterase Inhibitors.
- Author
-
Mahgoub, Mohamed Y., Elmaghraby, Awatef M., Harb, Abd-Elfttah A., Ferreira da Silva, João L., Justino, Gonçalo C., Marques, M. Matilde, Díez, David, and Castro, María Ángeles
- Subjects
- *
ACETYLCHOLINESTERASE inhibitors , *PYRIMIDINES , *ACETYLCHOLINESTERASE , *CRYSTAL structure , *MOLECULAR docking , *ALZHEIMER'S disease , *SINGLE crystals - Abstract
A new series of thiazolo[3,2-a]pyrimidine bromide salt derivatives 7a–d were synthesized from 3,4-dihydropyrimidinethione precursors. The target compounds were fully characterized by 1D- and 2D-NMR, high resolution ESI-MS/MS and single crystal X-ray diffraction analysis, which confirmed a regioselective 5H cyclization of the dihydropyrimidinethiones. All target compounds were evaluated in vitro as human acetylcholinesterase (hAChE) inhibitors via an Ellman-based colorimetric assay and showed good inhibition activities (better than 70% at 10 µM and IC50 values in the 1 µM range). Molecular docking simulations for all target products into hAChE were performed and confirmed strong binding to the enzyme. These results provide a promising and new starting point to improve acetylcholinesterase inhibitors and explore novel treatment options against Alzheimer's disease. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
139. Carbazole- and Triphenylamine-Substituted Pyrimidines: Synthesis and Photophysical Properties.
- Author
-
Achelle, Sylvain, Rodríguez-López, Julián, Larbani, Massinissa, Plaza-Pedroche, Rodrigo, Robin-le Guen, Françoise, and Paul, Frédéric
- Subjects
- *
CARBAZOLE , *PYRIMIDINES , *FLUORESCENCE , *NANOPARTICLES , *PHOTOLUMINESCENCE - Abstract
A series of pyrimidine derivatives bearing one, two or three triphenylamine/9-ethylcarbazole substituents has been synthesized by Suzuki cross-coupling reaction. All compounds showed absorption bands in the UV region and the emission of violet-blue light upon irradiation. Protonation led to quenching of the fluorescence, although some derivatives remained luminescent with the appearance of a new red-shifted band in the spectra. Accurate control of the amount of acid enabled white photoluminescence to be obtained both in solution and in solid state. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
140. Pyrimidine 2,4-Diones in the Design of New HIV RT Inhibitors.
- Author
-
Romeo, Roberto, Iannazzo, Daniela, Veltri, Lucia, Gabriele, Bartolo, Macchi, Beatrice, Frezza, Caterina, Marino-Merlo, Francesca, Giofrè, Salvatore V., and De Clercq, Erik
- Subjects
- *
PYRIMIDINES , *HIV infections , *ANTIRETROVIRAL agents , *T cells , *DRUG resistance - Abstract
The pyrimidine nucleus is a versatile core in the development of antiretroviral agents. On this basis, a series of pyrimidine-2,4-diones linked to an isoxazolidine nucleus have been synthesized and tested as nucleoside analogs, endowed with potential anti-HIV (human immunodeficiency virus) activity. Compounds 6a–c, characterized by the presence of an ethereal group at C-3, show HIV reverse transcriptase (RT) inhibitor activity in the nanomolar range as well as HIV-infection inhibitor activity in the low micromolar with no toxicity. In the same context, compound 7b shows only a negligible inhibition of RT HIV. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
141. A Validated HPLC-MS/MS Assay for 14-O-[(4,6-Diaminopyrimidine-2-yl)thioacetyl] Mutilin in Biological Samples and Its Pharmacokinetic, Distribution and Excretion via Urine and Feces in Rats.
- Author
-
Fu, Yunxing, Liu, Yu, Yi, Yunpeng, Liang, Jianping, Wu, Qingfeng, and Shang, Ruofeng
- Subjects
- *
PYRIMIDINES , *FUNCTIONAL groups , *GRAM-positive bacteria , *ACETONITRILE , *FECES - Abstract
14-O-[(4,6-Diaminopyrimidine-2-yl)thioacetyl] mutilin (DPTM), a novel pleuromutilin candidate with a substituted pyrimidine moiety, has been confirmed to possess excellent antibacterial activity against Gram-positive bacteria. To illustrate the pharmacokinetic profile after intravenous (i.v.), intramuscular (i.m.) and oral (p.o.) administrations with DPTM, as well as tissue distribution and excretion via urine and feces in vivo, a specific, sensitive and robust HPLC-MS/MS method was first developed to determine DPTM in rat plasma, various tissues, urine and feces. The plasma, tissues, urine and feces samples were treated by protein precipitation with acetonitrile using tiamulin fumarate as an internal standard (IS). This method which was achieved on an HPLC system detector equipped with an ESI interface, was sensitive with 5 ng/mL as the lower limit of detection and exhibited good linearity (R2 > 0.9900) in the range of 5–4000 ng/mL for plasma, various tissues, urine and feces, as well as intra-day precision, inter-day precision and accuracy. The matrix effects ranged from 94.2 to 109.7% with RSD ≤ 9.4% and the mean extraction recoveries ranged from 95.4 to 109.5% in plasma, tissue homogenates, urine and feces (RSD ≤ 9.9). After i.v., i.m. and p.o. administrations, DPTM was rapidly absorbed and metabolized in rats with the half-life (t1/2) of 1.70–1.86, 3.23–3.49 and 4.38–4.70 for 10, 25 and 75 mg/kg doses, respectively. The tissue distribution showed that DPTM was diffused into all the tested tissues, especially into the intestine and lung. Excretion via urine and feces studies demonstrated that DPTM was mainly excreted by feces after administration. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
142. Synthesis of New Furothiazolo Pyrimido Quinazolinones from Visnagenone or Khellinone and Antimicrobial Activity.
- Author
-
Abu-Hashem, Ameen Ali and Jampilek, Josef
- Subjects
- *
QUINAZOLINONES , *ALIPHATIC hydrocarbons , *PYRAZOLES , *PYRIMIDINES , *FUNGI diversity - Abstract
Substituted-6-methyl-1-thioxo-1,2-dihydro-3H-furo[3,2-g]pyrimido[1,6-a]quinazolin-3-ones (5a,b) were synthesized from condensation of visnagenone (2a) or khellinone (2b) with 6-amino-thiouracil (3) in dimethylformamide or refluxing of (4a) or (4b) in dimethylformamide. Hence, compounds (5a,b) were used as the starting materials for preparing many new heterocyclic compounds such as; furo[3,2-g]pyrimido[1,6-a]quinazoline (6a,b), furo[3,2-g]thiazolo[2′,3′:2,3]pyrimido[1,6-a]quinazolinone (7a,b), substituted-benzylidene-furo[3,2-g]thiazolo[2′,3′:2,3]pyrimido[1,6-a]quinazoline-3,5-dione (8a–f), 3-oxo-furo[3,2-g]pyrimido[1,6-a]quinazoline-pentane-2,4-dione (9a,b), 1-(pyrazole)-furo[3,2-g]pyrimido[1,6-a]quinazolinone (10a,b), 2-(oxo or thioxo)-pyrimidine-furo[3,2-g]pyrimido[1,6-a]quinazolinone (11a–d), 1-(methylthio)-furo[3,2-g]pyrimido[1,6-a]quinazolinone (12a,b), 1-(methyl-sulfonyl)-furo[3,2-g]pyrimido[1,6-a]quinazolinone (13a,b) and 6-methyl-1-((piperazine) or morpholino)-3H-furo[3,2-g]pyrimido[1,6-a]quinazolin-3-one (14a–d). The structures of the prepared compounds were elucidated on the basis of spectral data (IR, 1H-NMR, 13C-NMR, MS) and elemental analysis. Antimicrobial activity was evaluated for the synthesized compounds against Gram-positive, Gram-negative bacteria and fungi. The new compounds, furothiazolo pyrimido quinazolines 8a–f and 11a–d displayed results excellent for growth inhibition of bacteria and fungi. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
143. Regioselective Synthesis of New 2,4-(Het)aryl-3H-pyrido[1′,2′:1,5]pyrazolo[4,3-d]pyrimidines Involving Palladium-Catalyzed Cross-Coupling Reactions.
- Author
-
Ejjoummany, Abdelaziz, Belaroussi, Rabia, El Hakmaoui, Ahmed, Akssira, Mohamed, Guillaumet, Gérald, Buron, Frédéric, and Routier, Sylvain
- Subjects
- *
PYRIMIDINES , *PALLADIUM , *CATALYSIS , *SULFUR , *COUPLING reactions (Chemistry) - Abstract
The design of some novel di-(het)arylated-3H-pyrido[1′,2′:1,5]pyrazolo[4,3-d]pyrimidine derivatives is reported. The series was developed from 1-aminopyridinium iodide, which afforded the key intermediate bearing two thiomethyl and amide functions, each of them useful for palladium catalyzed cross coupling reactions by alkyl sulfur release and C-O activation, respectively. The two regioselective and successive cross-coupling reactions were first carried out in C-4 by in situ C-O activation and next in C-2 by a methylsulfur release. Process optimization furnished conditions leading to products in high yields. The scope and limitations of the methodologies were evaluated and the final compounds characterized. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
144. Synthesis, Design, and Structure–Activity Relationship of the Pyrimidone Derivatives as Novel Selective Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase.
- Author
-
Xu, Le, Li, Wenjie, Diao, Yanyan, Sun, Hongxia, Li, Honglin, Zhu, Lili, Zhou, Hongchang, and Zhao, Zhenjiang
- Subjects
- *
PLASMODIUM falciparum , *DIHYDROOROTATE dehydrogenase , *ANTIMALARIALS , *CHEMICAL reactions , *DEHYDROGENASES , *ANTINEOPLASTIC agents , *PYRIMIDINES - Abstract
The inhibition of
Plasmodium falciparum dihydroorotate dehydrogenase (Pf DHODH) potentially represents a new treatment option for malaria, asP. falciparum relies entirely on a de novo pyrimidine biosynthetic pathway for survival. Herein, we report a series of pyrimidone derivatives as novel inhibitors ofPf DHODH. The most potent compound,26 , showed high inhibition activity againstPf DHODH (IC50 = 23 nM), with >400-fold species selectivity over human dihydroorotate dehydrogenase (h DHODH). The brand-new inhibitor scaffold targetingPf DHODH reported in this work may lead to the discovery of new antimalarial agents. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
145. Design, Synthesis and Antitumor Evaluation of Novel Pyrazolopyrimidines and Pyrazoloquinazolines.
- Author
-
El-Naggar, Mohamed, Hassan, Ashraf S., Awad, Hanem M., and Mady, Mohamed F.
- Subjects
- *
ANTINEOPLASTIC agents , *PYRIMIDINES , *QUINAZOLINE , *ANTI-infective agents , *ANTIBACTERIAL agents , *CHEMICAL reactions , *CANCER cells - Abstract
A series of
N -aryl-7-aryl-pyrazolo[1,5-a ]pyrimidines18a –u andN -aryl-pyrazolo[1,5-a ]quinazolines25a –c were designed and synthesized via the reaction of 5-aminopyrazoles11a –c with enaminones12a –g or19 , respectively. The new compounds were screened for their in vitro antitumor activity toward liver (HepG-2) and breast (MCF-7) human cancer cells using 3-[4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H -tetrazolium bromide MTT assay. From the results, it was found that all compounds showed dose-dependent cytotoxic activities against both HepG-2 and MCF-7 cells. Two compounds18o and18a were selected for further investigations. Cell cycle analysis of liver (HepG-2) cells treated with18o and breast (MCF-7) cells treated with18a showed cell cycle arrest at G2/M phase and pro-apoptotic activity as indicated by annexin V-FITC staining. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.